E-LIB Suche - Ergebnisse für: Lechtzin, N.

1

717 Provider practices in management of pulmonary exacerbat..:

Toporek, A. ; Boyle, R. ; Patel, S....
Journal of Cystic Fibrosis. 22 (2023) - p. S396 , 2023

Link: https://doi.org/10.1016/..

2

681 Collecting and addressing social determinants of health..:

Mitchell, L. ; Scaljon, A. ; Smith, A....
Journal of Cystic Fibrosis. 22 (2023) - p. S374 , 2023

Link: https://doi.org/10.1016/..

3

P184 Sex differences in annual pulmonary exacerbations in p..:

Montemayor, K. ; Kevin, P. ; Lechtzin, N....
Journal of Cystic Fibrosis. 22 (2023) - p. S121 , 2023

Link: https://doi.org/10.1016/..

4

WS05.06 Phase 1/2a randomized, double-blind, placebo-contro..:

Cohen, A. ; Lechtzin, N. ; Boas, S....
Journal of Cystic Fibrosis. 22 (2023) - p. S11 , 2023

Link: https://doi.org/10.1016/..

5

627 Prevalence and predictors of high cardiovascular risk i..:

Merlo, C. ; Brookmeyer, C. ; Patel, S....
Journal of Cystic Fibrosis. 22 (2023) - p. S336-S337 , 2023

Link: https://doi.org/10.1016/..

6

582 Cholesterol levels increase on elexacaftor-tezacaftor-i..:

Boyle, R. ; Xia, J. ; Patel, S....
Journal of Cystic Fibrosis. 22 (2023) - p. S310 , 2023

Link: https://doi.org/10.1016/..

7

Inhaled mRNA therapy for treatment of cystic fibrosis: Inte..:

Rowe, S.M. ; Zuckerman, J.B. ; Dorgan, D....
Journal of Cystic Fibrosis. 22 (2023) 4 - p. 656-664 , 2023

Link: https://doi.org/10.1016/..

8

498 The cystic fibrosis Wellness Program to treat fatigue: ..:

Riekert, K. ; Green, A. ; Yablon, D....
Journal of Cystic Fibrosis. 22 (2023) - p. S262-S263 , 2023

Link: https://doi.org/10.1016/..

9

356 Establishment of primary sweat gland cultures suitable ..:

Eastman, A. ; Rosson, G. ; Kim, N....
Journal of Cystic Fibrosis. 22 (2023) - p. S180 , 2023

Link: https://doi.org/10.1016/..

10

P185 Prospective randomized observational study validating ..:

Liou, T.G. ; Argel, N. ; Asfour, F....
Journal of Cystic Fibrosis. 22 (2023) - p. S121-S122 , 2023

Link: https://doi.org/10.1016/..

11

319 Fatigue and poor sleep quality prevalent even in settin..:

Riekert, K. ; Allgood, S. ; Ayensu-Asiedu, C....
Journal of Cystic Fibrosis. 21 (2022) - p. S189-S190 , 2022

Link: https://doi.org/10.1016/..

12

280 Patient priorities for addressing aging related topics ..:

Mitchell, L. ; Allgood, S. ; Aulie, P....
Journal of Cystic Fibrosis. 21 (2022) - p. S166-S167 , 2022

Link: https://doi.org/10.1016/..

13

507 Phase 1/2a randomized, double-blind, placebo-controlled..:

Cohen, A. ; Lechtzin, N. ; McBennett, K....
Journal of Cystic Fibrosis. 21 (2022) - p. S286 , 2022

Link: https://doi.org/10.1016/..

14

P042 The effect of elexacaftor/tezacaftor/ivacaftor on non-..:

Allgood, S. ; Levy, R. ; Bubaris, D....
Journal of Cystic Fibrosis. 21 (2022) - p. S72 , 2022

Link: https://doi.org/10.1016/..

15

544: Safety and tolerability of single and repeat doses of ..:

Rowe, S. ; Dorgan, D. ; Lascano, J....
Journal of Cystic Fibrosis. 20 (2021) - p. S257 , 2021

Link: https://doi.org/10.1016/..